Kohei Nishikawa

3.9k total citations
118 papers, 3.3k citations indexed

About

Kohei Nishikawa is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kohei Nishikawa has authored 118 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Pharmacology and 26 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kohei Nishikawa's work include Inflammatory mediators and NSAID effects (23 papers), Eicosanoids and Hypertension Pharmacology (18 papers) and Renin-Angiotensin System Studies (11 papers). Kohei Nishikawa is often cited by papers focused on Inflammatory mediators and NSAID effects (23 papers), Eicosanoids and Hypertension Pharmacology (18 papers) and Renin-Angiotensin System Studies (11 papers). Kohei Nishikawa collaborates with scholars based in Japan, United States and Germany. Kohei Nishikawa's co-authors include Zen‐ichi Terashita, Yoshiyuki Inada, Aubrey R. Morrison, Yumiko Shibouta, Yoshimi Imura, Philip Needleman, Susumu Tsushima, Keiji Kubo, Takehiko Naka and Takeo Wada and has published in prestigious journals such as Nature, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Kohei Nishikawa

112 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohei Nishikawa Japan 28 1.1k 990 674 617 529 118 3.3k
M.J. Silver United States 27 1.1k 1.0× 784 0.8× 1.2k 1.7× 404 0.7× 722 1.4× 56 3.4k
B Samuelsson Sweden 13 940 0.9× 1.1k 1.1× 1.7k 2.5× 956 1.5× 939 1.8× 17 4.4k
K F Badr United States 29 623 0.6× 1.4k 1.4× 763 1.1× 1.3k 2.1× 1.4k 2.7× 51 5.2k
Martin L. Ogletree United States 37 986 0.9× 891 0.9× 781 1.2× 819 1.3× 626 1.2× 124 4.3k
Zen‐ichi Terashita Japan 25 506 0.5× 581 0.6× 394 0.6× 594 1.0× 319 0.6× 72 2.1k
R.J. Gryglewski Poland 23 701 0.7× 412 0.4× 478 0.7× 1.1k 1.8× 593 1.1× 56 2.4k
Aı̈da Habib France 35 842 0.8× 1.9k 1.9× 1.5k 2.2× 807 1.3× 713 1.3× 87 4.8k
Baichun Yang United States 25 664 0.6× 853 0.9× 268 0.4× 605 1.0× 1.4k 2.6× 53 3.3k
N Stanford United States 11 995 0.9× 609 0.6× 1.2k 1.7× 248 0.4× 458 0.9× 11 2.6k
Ulisse Garbin Italy 36 714 0.7× 1.0k 1.0× 332 0.5× 581 0.9× 230 0.4× 79 3.8k

Countries citing papers authored by Kohei Nishikawa

Since Specialization
Citations

This map shows the geographic impact of Kohei Nishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Nishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Nishikawa more than expected).

Fields of papers citing papers by Kohei Nishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Nishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Nishikawa. The network helps show where Kohei Nishikawa may publish in the future.

Co-authorship network of co-authors of Kohei Nishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Nishikawa. A scholar is included among the top collaborators of Kohei Nishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Nishikawa. Kohei Nishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nishihama, Kota, Kohei Nishikawa, Atsuro Takeshita, et al.. (2023). Bilateral Nephrectomy for Resistant Hypertension and Secondary Aldosteronism in a Hemodialysis Patient: A Case Report. Internal Medicine. 63(11). 1597–1602.
3.
Usami, Yoshihide, et al.. (2021). CuI-Catalyzed Coupling Reactions of 4-Iodopyrazoles and Alcohols: Application toward Withasomnine and Homologs. Molecules. 26(11). 3370–3370. 2 indexed citations
4.
Inoue, Takahiro, et al.. (2021). Warning against second‐generation antiandrogen for metastatic castration sensitive prostate cancer. British Journal of Urology. 128(5). 550–550. 1 indexed citations
5.
Ishii, Kenichiro, Takeshi Sasaki, Manabu Kato, et al.. (2019). Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure. Laboratory Investigation. 100(5). 670–681. 8 indexed citations
6.
Ishii, Kenichiro, et al.. (2010). Effect of transforming growth factor α overexpression on urogenital organ development in mouse. Differentiation. 80(2-3). 82–88. 4 indexed citations
7.
Noda, Masakuni, Takanori Matsuo, Ryo Fukuda, et al.. (1999). Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure. Kidney International. 56(3). 898–909. 43 indexed citations
8.
Ojima, M, et al.. (1999). Pharmacologic properties of candesartan cilexetil—possible mechanisms of long-acting antihypertensive action. Journal of Human Hypertension. 13(S1). S75–S80. 19 indexed citations
9.
Nishikawa, Kohei. (1998). Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage. Journal of Human Hypertension. 12(5). 301–309. 36 indexed citations
10.
Nishikawa, Kohei, Takehiko Naka, Masakuni Noda, et al.. (1996). Angiotensin II receptor antagonistic action of candesartan (CV-11974) in the rabbit aorta. 24(10). 121–126. 2 indexed citations
12.
Kawamura, Masaki, Yuki Imura, Hideto Fukushi, et al.. (1996). Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 502–510. 27 indexed citations
14.
Kawamura, Masaki, Zen‐ichi Terashita, Yuki Imura, A. Shino, & Kohei Nishikawa. (1993). Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation. Thrombosis Research. 70(4). 281–293. 15 indexed citations
15.
Kubo, Keiji, Yoshiyuki Inada, Yasuhisa Kohara, et al.. (1993). Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles. Journal of Medicinal Chemistry. 36(12). 1772–1784. 111 indexed citations
17.
Kubo, Keiji, Yasuhisa Kohara, Eiko Imamiya, et al.. (1993). Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids. Journal of Medicinal Chemistry. 36(15). 2182–2195. 117 indexed citations
18.
Imura, Yuki, Zen‐ichi Terashita, & Kohei Nishikawa. (1990). The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage. Thrombosis Research. 59(1). 195–205. 15 indexed citations
20.
MATSUMURA, HARUKI, et al.. (1986). Antagonism of collagen-induced ECG changes in rats by a thromboxane synthetase inhibitor, CV-4151.. Folia Pharmacologica Japonica. 87(4). 397–404. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026